Results 111 to 120 of about 33,935 (242)
Early systemic intervention for vitiligo: A prospective bicentric interventional study
Patients with non‐segmental vitiligo were enrolled into three groups according to the duration and activity of their disease. All subjects received NB‐UVB phototherapy and an oral mini‐pulse of systemic corticosteroids twice weekly for 6 months. Early systemic treatment allows better repigmentation, including in difficult‐to‐treat areas.
Clemence Bertold +8 more
wiley +1 more source
Female genital lichen sclerosus
This review provides a comprehensive overview of clinical presentation and emerging evidence supporting a predominantly immune‐mediated pathogenesis characterized by Th1‐skewed inflammation, epithelial dysfunction and progressive fibrosis. Contributory factors including the emerging role for occlusive exposure of susceptible epithelium to urine are ...
Ashley Spencer, Sandra Jerkovic Gulin
wiley +1 more source
Vitiligo Pathogenesis, Diagnosis And Therapy
Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of the population worldwide. The disease is characterized by the selective loss of melanocytes which results in typical nonscaly, chalky-white macules.
Codița, L. (Laurenția) +1 more
core
Obesity‐associated transcriptomic remodelling in hidradenitis suppurativa and treatment response
This review highlights that adiposity systemically primes HS through adipokine dysregulation and insulin resistance, contributing to lesional metabolic reprogramming and perilesional barrier dysfunction. Current evidence indicates that obesity exacerbates disease severity and attenuates responses to biologic therapies, supporting the classification of ...
Sahil Kapur +9 more
wiley +1 more source
A Case of Inflammatory Vitiligo
Vitiligo is common dermatologic disorder, but inflammatory vitiligo is a rare occurrence that is characterized by erythematous rim at the periphery of a patch of hypopigmented skin.
박윤기
core +2 more sources
Melanocyte Destruction in Vitiligo
Explaining the histology behind Vitiligo and the differences between a person who has vitiligo and a person who does ...
Guarino, Bianca
core
Thirty Years of Autologous Platelet Concentrates: From Platelet‐Rich Plasma to Platelet‐Rich Fibrin
This review highlights the 30 years of evolution of APCs, with a focus on their clinical applications and recent technological advancements. ABSTRACT Nearly three decades have now passed since autologous platelet concentrates (APCs) were introduced into clinical practice.
Richard J. Miron +7 more
wiley +1 more source
Vitiligo and social acceptance
Reza Bidaki,1 Niloofar Majidi,2 Amir Moghadam Ahmadi,3 Hamid Bakhshi,4 Rezvan Sadr Mohammadi,5 Seyed-Ali Mostafavi,6 Mohammad Kazemi Arababadi,7 Maryam Hadavi,8 Afshin Mirzaei9 1Research Center of Addiction and Behavioral Sciences, Diabetes Research ...
Sadr Mohammadi R +8 more
core
Vitiligo treatment: a literature review
Vitiligo is a chronic disease characterized by the focal damage of melanocytes, which results in formation of discoloured spots on the skin. This disease affects from 0.5% to even 4% of the general population and the first symptoms appear before the ...
Adrianna P. Pyrek +3 more
core +1 more source
Enfermedad ocular y auditiva asociada al vitiligo [PDF]
Vitiligo is a pigmentation disorder of unclear origin secondary to the loss of function of melanocytes, which could compromise not only epidermal melanocytes but also those established in other organs suggesting the presence of concomitant diseases such ...
Casas, Mirian Yolanda +1 more
core

